Skip to content
Toggle main navigation
Cure HHT logo
Cure HHT logo
  • Cure HHT Research Network
  • About
  • Resources
    • Scientific Conference
    • CME
    • International HHT Guidelines
    • CHORUS
    • Research Roadmap
  • CureHHT.org
    Log in
    Request to join
    Contact
    Cure HHT
    ResearchNetwork@curehht.org
    Community engagement platform by Hivebrite.

    News and Announcements

    The latest news and announcements from Cure HHT related to the medical and scientific community.

    Submit Your News Here!
    Filter by category
    All
    Basic Science
    Brag board
    Case Report
    Cure HHT News
    Editorial
    Events and Conferences
    Funding announcements
    International
    Primary Manuscript
    Publication alerts
    See all

    Results (14)

    New MASAC Recommendations on Iron Deficiency

    New MASAC Recommendations on Iron Deficiency

    MASAC Recommendations on Iron Deficiency in Bleeding DisordersWe’re pleased to share a newly published set of recommendations from the National Bleeding Disorders Foundation (NBDF) Medical and Scientific Advisory Council (MASAC), focused on the screening and management of iron deficiency and iron deficiency anemia (IDA) in individuals with inherited bleeding disorders.This publication represents a
    March 20, 2026
    PUBLISHED! 2024 Conference Summary Available!

    PUBLISHED! 2024 Conference Summary Available!

    15th HHT International Scientific Conference — Summary & Abstracts Now AvailableWe’re excited to announce that the Executive Summary and Oral Presentation Abstracts from the 15th HHT International Scientific Conference, held in Mandelieu-la-Napoule, France, has now been published in Angiogenesis and is available for download.This comprehensive publication highlights the latest scientific, translat
    November 20, 2025
    2025 NOV 17 Publication List

    2025 NOV 17 Publication List

    A lot of great publications out from the last two weeks! Enjoy! 1.Splenomegaly in a Patient with Hereditary Hemorrhagic Telangiectasia.Noritomi D, Kido T, Ozasa M, Ishijima S, Sakamoto N, Mukae H.Am J Med. 2025 Nov 13:S0002-9343(25)00799-5. doi: 10.1016/j.amjmed.2025.11.003. Online ahead of print.PMID: 41241117 No abstract available.2.Treatment outcomes of cerebral arteriovenous malformations in p
    November 17, 2025
    International HHT Researchers Collaborate on Nature Reviews Article

    International HHT Researchers Collaborate on Nature Reviews Article

    An international team of HHT researchers has published a comprehensive review on Hereditary Hemorrhagic Telangiectasia (HHT) in Nature Reviews Disease Primers. This review provides an in-depth overview of HHT, covering the latest insights into its genetic basis, clinical manifestations, diagnostic strategies, and emerging therapeutic approaches.This collaborative effort highlights the global commi
    January 12, 2025
    PATH Trial for HHT Published in NEJM!

    PATH Trial for HHT Published in NEJM!

    The NIH-Sponsored PATH Trial Becomes First Positive Randomized Clinical Trial for HHT A huge congratulations to the investigators of this trial, the site PIs, coordinators, and importantly, the patients. NIH Press ReleasePublication Link (also attached)NEJM Quick Take Video
    September 20, 2024
    Screening Rationale for Children with HHT for Brain VMs

    Screening Rationale for Children with HHT for Brain VMs

    'The “watch and wait” approach to imaging means that children with brain vascular malformations will not be identified until a potentially life-threatening and deficit-producing intracerebral hemorrhage occurs. This expert group does not deem this to be an acceptable trade-off.' In this paper, expert providers and advocates review current screening guidelines for children with HHT and provide evid
    July 14, 2024
    Consensus Guidelines for Variant Interpretation in ENG and ACVRL1

    Consensus Guidelines for Variant Interpretation in ENG and ACVRL1

    A group of HHT researchers was assembled to serve on a 'Variant Curation Expert Panel (VCEP)' to develop criteria for evaluating the pathogenicity of variants in ENG and ACVRL1 and to review variants in the ClinGen database. Their recent publication details the modifications made to variant interpretation guidelines of the American College of Medical Genetics and Genomics (ACMG) and the Associatio
    May 30, 2024
    Sekarski Spreads HHT Awareness

    Sekarski Spreads HHT Awareness

    Sekarski_et_al_2024.pdfThank you, Lynne Sekarski, for spreading awareness about HHT through your recently published case report and presentation at the Society of Pediatric Nurses conference. Please read and share with a colleague who does not work with HHT patients. I will be sharing this with a friend who is an emergency room nurse. Remember, when we diagnose 1 person with HHT, we likely diagnos
    May 6, 2024
    Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors

    Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors

    AbstractHeterozygous activin receptor-like kinase 1 (ALK1) mutations are associated with two vascular diseases: hereditary hemorrhagic telangiectasia (HHT) and more rarely pulmonary arterial hypertension (PAH). Here, we aimed to understand the impact of ALK1 mutations on BMP9 and BMP10 transcriptomic responses in endothelial cells. Endothelial colony-forming cells (ECFCs) and microvascular endothe
    February 6, 2024
    Manuscript Summary - ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia

    Manuscript Summary - ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia

    ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic TelangiectasiaPublished on June 8, 2023A new study from the lab of Dr. Stryder Meadows at Tulane University – Summarized by Adella Guidroz and Shreya Bavishi The General Question: Is elevated angiopoietin 2 (ANG2) in the endothelium a conserved feature in mouse models of HHT that can be
    January 30, 2024
    PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life

    PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life

    Late Breaking Abstract: PATH-HHT STUDY Click above to read the late-breaking abstract submission to the American Society of Hematology Conference in December 2023. This abstract was featured as an oral presentation and details the outcomes of the recently concluded NIH-supported clinical trial 'Pomalidomide for the Treatment of Bleeding in HHT (PATH-HHT)'.  Find more information on the trial here.
    December 14, 2023
    Who Runs the World? Highlighting Research on Women and Girls With Bleeding Disorders - HHT in the News

    Who Runs the World? Highlighting Research on Women and Girls With Bleeding Disorders - HHT in the News

    Abstract featuring HHT pulled into ASH Daily News article highlighting women and girls with bleeding disorders Who Runs the World? Highlighting Research on Women and Girls with Bleeding Disorders Ellen Zhang, MD from Stanford, in collaboration with Vanderbilt University and Mass General Hospital, presented work analyzing the impact of inherited bleeding disorders HHT and VWS on women to determine
    December 14, 2023
    Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT

    Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT

    A new study from the Brain Vascular Malformation Consortium (BVMC) HHT Investigator Group - Summarized by Cassi FridayThe General Question: Are kids the same as adults in terms of brain vascular malformations related to HHT? The Problem: Before this study, there was not a lot of information published looking at brain vascular malformations in children, the symptoms these malformations cause, their
    December 9, 2023
    ASH Clinical News - Hematologists Should Take Primary Management Role

    ASH Clinical News - Hematologists Should Take Primary Management Role

    In a recent article published in November 2023 in the American Society of Hematology Clinical News, HHT clinicians Hanny Al-Samkari and Adrienne Hammill were interviewed about a hematologist's role in the management of patients with HHT. Read the Article Here Thank you for spreading awareness about HHT through this article to the ASH community.
    November 22, 2023